Comparison of oral versus intravenous clodronate in patients with skeletal metastasis with respect to bone mineral density and pain score
Pakistan Journal of Physiology. 2017; 13 (4): 23-25
em Inglês
| IMEMR
| ID: emr-198453
ABSTRACT
Background:
Clodronate is a bisphosphonate available both in oral as well as intravenous formulations. It is one of the effective drugs painful skeletal metastasis. The present study aimed at comparison of oral vs intravenous formulation with regard to improvement in bone mineral density and pain score among patients having skeletal metastasis
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Idioma:
Inglês
Revista:
Pak. J. Physiol.
Ano de publicação:
2017
Similares
MEDLINE
...
LILACS
LIS